NCT07376629 2026-01-29
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Huabo Biopharm Co., Ltd.
Phase 2 Enrolling by invitation
Clinical Trials
5 trialsNCT06848088 2026-01-12
A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
Regeneron Pharmaceuticals
Phase 2 Enrolling by invitation
NCT04093570 2025-10-31
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Taiho Oncology, Inc.
Phase 2 Enrolling by invitation
NCT06544798 2025-10-16
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
MeiraGTx UK II Ltd
Phase 2 Enrolling by invitation
NCT03628612 2025-08-07
Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
Autolus Limited
Phase 2 Enrolling by invitation